Back to top
more

Pfizer (PFE)

(Real Time Quote from BATS)

$28.88 USD

28.88
8,857,497

+0.43 (1.51%)

Updated Oct 28, 2024 11:38 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 14% (36 out of 250)

Industry: Large Cap Pharmaceuticals

Better trading starts here.

Zacks News

Sweta Killa headshot

Energy on Track for Its Best Month Ever: 5 ETF, Stock Winners

The S&P 500 Energy Index is on track for the best month ever, gaining nearly 40%.

Mark Vickery headshot

Black Friday 2020 Has a New Look

$10.3 billion in Black Friday revenues are expected online today, growing 33% year over year.

Kinjel Shah headshot

Pharma Stock Roundup: AZN COVID-19 Vaccine Interim Data, PFE Emergency Use Appeal

AstraZeneca (AZN) COVID-19 vaccine candidate proves effective in late-stage study. Pfizer (PFE) seeks Emergency use for its COVID-19 vaccine candidate.

Equinor (EQNR) Jumps 26.1% MTD: What's Driving the Rally?

Improving oil prices on encouraging coronavirus vaccine news aid Equinor (EQNR).

    4 Consumer Discretionary Gainers From Positive Vaccine News

    Positive vaccine news along with a steady rise in consumer spending bode well for discretionary stocks, making it a good time to invest in names like Malibu Boats (MBUU) and YETI Holdings (YETI).

    Daniel Laboe headshot

    Bear Of The Day: Simon Property Group (SPG)

    Simon Property Group (SPG) is starting to feel the adverse implications of the declining retail sector

    Sheraz Mian headshot

    Top Stock Reports for NVIDIA, Pfizer & Abbott

    Today's Research Daily features new research reports on 16 major stocks, including NVIDIA (NVDA), Pfizer (PFE) and Abbott Laboratories (ABT).

    Moderna (MRNA) Inks Europe Supply Deal for COVID-19 Vaccine

    Moderna (MRNA) signs a deal to supply up to 160 million vaccine doses to European Commission The vaccine is under review in Europe.

    UPS Soars 71.1% in the Past 6 Months: More Room for Rally?

    The surge in e-commerce demand in the current pandemic scenario bodes well for the UPS stock.

    BP Jumps 38.3% Month To Date: What's Driving the Rally?

    Improving oil prices on encouraging coronavirus vaccine news aid BP plc (BP).

    Wall Street Set to Close the Year Higher: 5 Top Growth Picks

    The stock market is poised to close the year positively, driven by a flurry of encouraging developments, making it a good time to invest in growth stocks like Beazer Homes (BZH) and Axcelis (ACLS).

    Stock Market News for Nov 25, 2020

    The Dow crossed the 30,000 points mark on Tuesday as investors hoped for a swift economic recovery following progress in coronavirus vaccine development and transition of President-elect Joe Biden to the White House.

    Sweta Killa headshot

    Dow Tops 30,000: 5 Stocks Driving the ETF

    The Dow Jones topped the 30,000 milestone for the first time on vaccine optimism, and improving prospects for the smooth transition of President-elect Joe Biden to White House.

    Should Value Investors Pick Pfizer (PFE) Stock Right Now?

    Is Pfizer (PFE) a great pick from the value investor's perspective right now? Read on to know more.

    Sweta Killa headshot

    Small-Cap ETF (DWAS) Hits New 52-Week High

    This small-cap ETF hits a new 52-week high. Are more gains in store for this ETF?

    Devyani Chamria headshot

    3 mREIT Stocks to Buy Amid Vaccine Hopes & Thanksgiving Cheer

    The overall optimism in the market, thanks to the positive news on the vaccine front and strong rebound in the economy creates a favorable backdrop for mortgage REITs like AGNC, NLY, and RC.

    Vaccine News Propels Market Higher: 5 Potential Gainers

    Promising vaccine news aided the market in moving higher with further economic recovery in sight, making it a good time to invest in fundamentally sound names like EnPro (NPO) and APi Group (APG).

    Tirthankar Chakraborty headshot

    Thanksgiving Brings Strong Seasonal Market Trends: 5 Picks

    Traditionally, the stock market tends to perform well from the Thanksgiving week till the end of the year. This calls for investing in growth stocks like General Motors (GM) & Malibu Boats (MBUU).

    Nilanjan Banerjee headshot

    Permian Producers in Focus as Crude Price Picks Up

    Improving oil prices are definitely a boon for Permian explorers like Devon (DVN), Diamondback (FANG), Concho (CXO) and Matador (MTDR).

    Sanghamitra Saha headshot

    Dow Hits 30K for First Time: 7 Stocks Driving the ETF Rally

    Wall Street seemed super-excited as the Dow Jones reached 30,000 for the first time in history on Nov 24.

    Sanghamitra Saha headshot

    ETFs to Play as Vaccine News Looks to Outdo Virus Fear

    After almost a year-long wait, the month of November started delivering sweet surprises to investors in the form of back-to-back vaccine news.

    The Zacks Analyst Blog Highlights: Gilead, Eli Lilly, Incyte and Pfizer

    The Zacks Analyst Blog Highlights: Gilead, Eli Lilly, Incyte and Pfizer

    Sweta Killa headshot

    Spread of Top-Ranked Value ETFs to Bet on Vaccine Optimism

    The potential arrival of a coronavirus vaccine will end the pandemic crisis, keeping the economy recovery intact, and will boost consumer spending and in turn lift value stocks.

    Pfizer (PFE) Begins Phase III Study on Hemophilia Candidate

    Pfizer (PFE) doses the first participant in the late-stage BASIS study, currently investigating marstacimab to address severe hemophilia A or B with or without inhibitors.

    Kinjel Shah headshot

    How Does AstraZeneca's COVID-19 Vaccine Data Compare to Others'?

    Interim data from late-stage studies on AstraZeneca (AZN) COVID-19 vaccine shows that the candidate was, on an average, about 70% effective in preventing COVID-19.